GL1X · GenesisL1 explorer

MolNFT v1 · #98171 · protein

Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1

4L19 · Collagenase 3: “Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1”. X-ray diffraction, 3 ligands (1UA, ZN, CA), 2 pockets (best druggability 0.71). MolNFT v1 #98171 on GenesisL1: 3D structure, binding sites…

PDB
4L19
Type
protein
Length
336 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Collagenase 3
EC
3.4.24.-
UniProt
P45452
Ligands
1UA, ZN, CA
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACollagenase 3 (EC 3.4.24.-)protein16624% helix, 19% strandP45452
BCollagenase 3 (EC 3.4.24.-)protein17024% helix, 18% strandP45452

Ligands and binding sites

  • 1UA · 2-[(4-methylbenzyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one · ligand · 3 copies · chains A, B
  • ZN · Zinc ion · metal · 5 copies · chains A, B
  • CA · Calcium ion · metal · 4 copies · chains A, B
  • FMT · Formic acid · additive · 5 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18500.710.7679FMT, 1UA, GOL
22770.580.7840FMT, 1UA

Interfaces

1 interface between chains.

  • A–B · 1233 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 4L19 · Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.